Second quarter 2020


Sanofi H1 2020 business EPS growth of 9.2% driven by transformation

Second quarter 2020 results were reviewed by management during a conference call with the financial community.

(14:30 CEST)

As we continue to face the global COVID-19 pandemic, I'm proud to say that Sanofi's employees once again put patients first while remaining focused on following through on our strategic priorities in the second quarter.

Paul Hudson

Chief Executive Officer



Clinical trials appendix

Press release

Q2 2020 income statements, cash flow statements, balance sheet

Q2 2020 net sales by GBU, franchise, geographic region and product

Download infographic